Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial
Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded an Auto-PubMed note indicating publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2; removed the older PubMed note and revision v3.2.0.SummaryDifference0.1%

- Check16 days agoChange DetectedThe operating-status notice about government funding has been removed from the page. The clinical trial details and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check24 days agoChange DetectedUpdated the site location label from 'Tainan City, Taiwan' to 'Tainan, Taiwan' in the Locations section.SummaryDifference0.1%

- Check31 days agoChange DetectedThe study record appears updated with minor textual clarifications and a refreshed last-updated date, while the primary trial details and listed sites remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedMajor update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.SummaryDifference4%

- Check66 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.